Elderly patients account for 42 -52% of intensive care unit (ICU) admissions and for almost 60% of all ICU days in the USA and up to 50% receive inappropriate antibiotic treatment. The aim of this study was to evaluate whether adherence to Standard Operating Procedures (SOPs) reduced ICU mortality in an elderly population.
Introduction
According to the Institute of Medicine in Washington DC, preventable adverse events in the USA, including hospital-acquired infections, are responsible for 44 000 -98 000 deaths annually and represent a cost of $17 -$29 billion, ahead of breast cancer, AIDS and motor vehicle accidents. 3, 4 Patients ≥ 65 years of age currently account for 42 -52% of intensive care unit (ICU) admissions in the USA and for almost 60% of all ICU days. 5
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Old age is associated with decreased cardiopulmonary and renal reserve, and with a high rate of comorbidities, increasing the risks for the development of multiple organ failure. 6 Thus, appropriate antimicrobial therapy might play a key role in the management of geriatric patients, adding fundamentally to patients' safety. Given the association between antimicrobial use and the selection of resistant pathogens, 7 -9 the frequency of inappropriate antimicrobial control is often used as a surrogate marker for the avoidable impact on antimicrobial resistance. 10, 11 Consequently, adequate treatment by means of guideline conformity may counter-play some preventable adverse effects. Reports on adherence to evidence-based medicine (EBM) guidelines have found adherence rates of 20 -30%; 12 -14 therefore, EBM in clinical routine is not widely implemented. Guidelines can, however, facilitate the development of local Standard Operating Procedures (SOPs) for antimicrobial therapy with due consideration to local resistance rates. An implementation rate of approximately 70% accounts for a laudable adherence to SOPs. 15 -17 The primary outcome measure of the study was to determine whether high adherence rates to SOPs, based on both EBM guidelines for the diagnosis and treatment of infections, and on local resistance rates, reduced ICU mortality rates in elderly patients.
Patients and methods

STUDY DESIGN, LOCATION AND PATIENTS
The study was a prospective, observational, cohort study, with retrospective expert team control, that was approved by the ethics review board of the Charité-Universitätsmedizin Berlin and Data Safety Authorities, Berlin. The ethics review board waived the need for patient informed consent to be obtained. Data were collected during a 3-month period from January to March 2006 from five ICUs (one cardiosurgical, one neurosurgical, two interdisciplinary, one intermediate care) under anaesthesiology management at the Charité-Universitätsmedizin Berlin. Every consecutive patient admitted to the ICUs was screened. The patients admitted to the ICUs were those who had undergone surgery and patients with medical or neurological illnesses. The only exclusion criteria were: age < 60 years; ICU stay < 3 days (because early death in the first 48 h is believed to be seldom related to treatment); and a primary diagnosis of sepsis (because septic patients follow their own set of SOPs 18 ).
INFECTION DIAGNOSIS
Local criteria for the diagnosis of infections were based on a modified Centers for Disease Control and Prevention definition and on the American Thoracic Society and Infectious Diseases Society of America joint committee guidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated pneumonia. 19, 20 DATA COLLECTION Data were recorded during daily rounds from medical records, hospital mainframe computer records and from a Patient Data Management System (PDMS) (Computer Organized Patient Report Assistant [COPRA]; COPRA-System GmbH, Sasbachwalden, Germany). Data were collected daily. The Therapeutic Intervention Scoring System (TISS), Simplified Acute Physiology Score II (SAPS II) and Sequential Organ Failure Assessment (SOFA) scores were recorded, which are part of a core data set for German ICUs (www.dgai.de/downloads/Kerndatensatz-Intensivmedizin-DGAI.pdf).
Data for microbiological and radiological I Nachtigall, M Deja, S Tafelski et al. Adherence to SOPs is crucial for ICU survival diagnostics, anti-infective, vasopressive and steroid agents, vital signs, laboratory findings, ventilation, pulmonary gas exchange, urine output and fluid balance were taken from the PDMS (COPRA). The PDMS was missing < 1% of data. Daily documentation and collection of data guaranteed a high percentage of collected data.
Factors predisposing for infection, such as immune suppression, or alcohol, drug or nicotine abuse, were taken from patients' data files. Immune suppression was defined as occurring in those patients taking corticosteroids or other immunosuppressive agents, those having HIV or leukaemia, or in patients following chemotherapy.
Adherence to SOP was recorded during data collection by the data collecting team, but was scored afterwards by an independent data monitoring expert committee (see next section: 'SOPs for antibiotic treatment'). Scoring was based on patient data sets for day-to-day SOP adherence to antibiotic treatment, with the adherence rate calculated as the number of days' adherence to SOP divided by the total number of days in the ICU.
SOPS FOR ANTIBIOTIC TREATMENT
The SOPs for antimicrobial therapy were developed by an expert committee comprising critical care physicians and microbiologists. They were based on recommendations from international guidelines and on local resistance rates, and formed part of the quality management system of the Department of Anaesthesiology and Intensive Care Medicine at the Charité-Universitätsmedizin Berlin 21 with each departmental staff member owning a copy. In addition, the book and computer-based files were easily accessible in all wards involved in the study. The SOPs included not only recommendations for calculated and targeted therapy, but also diagnostic guidance. The SOP algorithms are shown in the Appendices.
Adherence to the SOPs was recorded on a daily basis by the data collecting team and was revised after data collection by an independent data monitoring expert committee of three of the authors (Petra Gastmeier, Elke Halle and Torsten Bauer) who were unblinded to the patients and the data collecting part of the study, but blinded to the results of the adherence ratings of the study team. The expert committee members had open access to every patient's data file and were able to scrutinize the data randomly. Discrepancies to the SOPs consisted of one or more of the following: lack of attention to prior antibiotic regimen; insufficient diagnostic procedures; delayed or excessive antibiotic use; use of unsuitable antibiotic combinations or missed administration of a combination partner; inappropriate antibiotic administration; and lack of indication due to absence of infection. For evaluation of adherence to the SOPs, if any diagnostic or antibiotic prescriptive SOP was not followed, the day was scored as non-adherent. Only if the SOPs were insufficient for the specific needs of a patient, e.g. due to resistant strains or underlying diseases, was an aberrant treatment counted as adherence.
GROUP ASSIGNMENT
A cut-off implementation rate of 70% was taken for assignment to the low (LAG) or high (HAG) adherence groups. This was based on the following considerations: (a) this value is a quality indicator for the ICU implementation rate in the certified quality assurance policy ( 15 -17 (c) in analysing different cutoff values from the receiver operating characteristic (ROC) curve, the 70% cut-off (next to the 60% cut-off) for SOP adherence expressed the maximal sum of sensitivity and specificity in relation to mortality (Fig.  1 ). The HAG was, therefore, defined as an adherence to SOPs in > 70% of the ICU days and the LAG was defined by an adherence to SOPs in ≤ 70% of the ICU days.
STATISTICAL ANALYSIS
Results are expressed as arithmetic mean ± SE, median (interquartile range) or as frequencies (%). Differences between HAG and LAG in terms of clinically interesting parameters were tested using the nonparametric Wilcoxon-Mann-Whitney test and the χ 2 test in contingency tables. Due to sample size differences all tests were carried out in an exact version. Differences in mortality were tested both univariately and multivariately using logistic regression. Survival rates for both treatment groups were estimated according to the Kaplan-Meier method and compared univariately with log-rank statistics. In order to test multivariately for confounding factors, the multivariate Cox proportional hazard regression was applied. Hazard ratios (HR) with 95% confidence intervals (CI) and the corresponding P-values were calculated for each risk factor. A two-tailed P-value < 0.05 was considered statistically significant. Due to the exploratory nature of the study, all statistical tests were performed without any adjustment for multiple comparisons. All numerical calculations were performed with the Statistical Package for Social 
Results
PATIENTS
In total 349 consecutive patients were screened. Prior to screening, however, three patients were excluded due to their unusually long length of ICU stay (111, 120 and 206 days, respectively). From the screened patients, 228 patients with ≥ 3 consecutively observed days in the ICU and age ≥ 60 years were included in the study (Fig. 2 ). This gave a total of 1901 patient days to be analysed for SOP adherence. Basic patient characteristics and comorbidities did not differ between HAG and LAG ( Table 1) .
Inadequate antibiotic therapy occurred on 265 LAG and 27 HAG patient days. Delayed antibiotic treatment was observed on 37 LAG patient days versus 3 HAG patient days.
LENGTH OF ICU STAY AND TIME ON VENTILATOR
The median (interquartile range) length of stay in the ICU was 7 (12) days in the LAG Table 1 ).
MORTALITY
In total 26 patients died; 8/137 (5.8%) of the HAG patients and 18/91 (19.8%) of the LAG patients (odds ratio [OR] 0.25; 95% CI 0.10, 0.61; P = 0.002). The influence of SOP adherence on mortality was multivariately analysed by logistic regression including age, gender, immune suppression, nicotine and alcohol use disorders, SOFA, TISS, SAPS II scores at time of admission and surgery as covariates. The risk of death in the HAG, was one-fifth of the risk in the LAG (OR 0.194; 95% CI 0.072, 0.522; P = 0.001) ( Table 2 ). Kaplan-Meier method and univariately tested between the two groups (P = 0.04, logrank test; Fig. 3 ). Median survival time was 31.0 days in the LAG (95% CI 19.9, 42.1) and 41.0 days in the HAG (95% CI 29.3, 52.7). In order to test for confounding factors, the ; P = 0.027), immune suppression (HR 0.124; 95% CI 0.022, 0.704; P = 0.018) and SOFA score at admission (HR 1.236; 95% CI 1.021, 1.496; P = 0.030) were significant risk factors for death. As for the primary outcome (SOP adherence), risk of death in the HAG was less than one-third of the risk in the LAG (HR 0.305; 95% CI 0.112, 0.828; P = 0.020) ( Table 3 ).
SURVIVAL TIME
Discussion
The most important findings of this study were, first, that mortality rate was lower for elderly patients in the HAG compared with patients in the LAG. To the best of our knowledge, our study is the first to show that following SOPs that consider evidence-based guidelines and local resistance rates for antibiotic therapy improves outcome in elderly patients. Secondly, length of stay in the ICU and duration of mechanical ventilation were significantly reduced in the HAG.
The implementation of guidelines is urgently requested in many fields of medicine. 22 -24 Previous studies have shown that following guidelines in other critically ill patient groups improves outcome. 18, 25, 26 Price et al. 27 showed that implementation of guidelines reduced the costs of antibiotic treatment without adversely affecting patients' outcome, and indicated a trend towards lower mortality rates for patients treated according to guidelines. Menéndez et al. 28 demonstrated that non-adherence to guidelines in the treatment of communityacquired pneumonia is an independent risk factor for treatment failure and mortality. Evans et al. 29 designed a computer system that guided antibiotic treatment and were able to show a reduction in hospital and antibiotic costs, and length of hospital stay.
In our study there was inadequate antibiotic treatment in 265 LAG and in 27 HAG patient days. An infection with a causative pathogen that is not being effectively treated can influence patient outcome, 30 -32 accordingly inadequate antimicrobial treatment is an independent risk factor for death among critically ill I Nachtigall, M Deja, S Tafelski et al. Adherence to SOPs is crucial for ICU survival patients. 33, 34 Other studies have shown a lack of association between microbiologically inadequate therapy and increased mortality, which can be explained by the inclusion of patients without life-threatening infections, small sample sizes or the influence of confounding factors and bias. 31 In the present study a delay in antibiotic treatment was observed in 37 LAG versus 3 HAG patient days. Delayed therapy, even with the appropriate antibiotic, has been shown to be associated with a higher mortality in patients with ventilatorassociated pneumonia. 11 However, since we collected data for delay only in the dimension of days this factor may be underestimated in our study.
Length of stay in the ICU and duration of ventilation in our study were shorter in the HAG compared with the LAG. This is consistent with previous studies showing shorter periods of mechanical ventilation 35, 36 and a shorter length of stay in the ICU in guideline-treated groups. 37, 38 Our study focused on the elderly, who form the fastest growing segment of the population in the Western world. Since this population has high ICU mortality, it is helpful that our findings have shown an effect at an early time point. Nicolas et al. 39 reported that ICU mortality increased progressively with age, therefore, for ageing patients it is even more crucial to be treated in the most optimum manner. In other studies that have investigated SOP implementation, the average age of patients was also > 60 years, although they did not specifically focus on this patient population. 18, 25, 35, 38 Basic patient characteristics did not differ between HAG and LAG patients The ICU scores (SOFA, TISS and SAPS II) also did not differ between the two patient groups at admission however, over time, SAPS II was significantly increased in the LAG. This corresponds well with the findings described above because SAPS II was designed for evaluation of in-hospital mortality, assigning to each patient an increasing score as severity of illness increases. 40 SAPS II is independent of the principal diagnosis and, therefore, improves comparability of the severity of illness in the ICU. Daily scores also help to capture the intensity of resource use and may help us to gain a better understanding of what is truly ICU-acquired organ dysfunction. 41 Besides looking at SOP adherence using a 70% cut-off, we further examined all the discussed clinical parameters with a 60% cut-off and reached the same significant results (data not shown).
A limitation of our study is that it included SOPs that are locally adapted, so that we do not know whether our findings would be reliable for other local resistance rates. This is, however, also a strength of our study in that it demonstrates how helpful locally adapted SOPs are that deal with given circumstances for microbiological resistance and drug availability. A further strength of our study was the blindness of the independent data monitoring expert committee.
Only elderly patients were considered in our study and the situation may be different for other age groups. Elderly patients are, however, much more prone to suffer from long-term sequelae of multiple organ dysfunction due to inadequate treatment. Circannual variation in mortality is a wellrecognized phenomenon in geriatric patients and has been described elsewhere. 42 Due to the relatively short duration of our study it is unlikely that seasonal changes played a role in the study outcome; future studies are needed to examine this aspect thoroughly.
Patients with a primary diagnosis of sepsis were excluded from our study because they I Nachtigall, M Deja, S Tafelski et al. Adherence to SOPs is crucial for ICU survival followed the international sepsis bundle guidelines. 43, 44 The sample size of our study was not planned in advance to differentiate for adherence in specific areas of infection.
Since this was an observational study and confounding factors can have substantial effects, the outcomes for other settings are difficult to predict. We also cannot exclude the possibility of bias due to a particularly skilled doctor following the guidelines.
It was not possible for the present study to have a randomized design because we believe that following SOPs is crucial for the outcome of patients and it would have been unethical knowingly to expose patients to inadequate treatment.
Not only survival, but also quality of life is an important outcome measure and this was not followed-up in our study.
In conclusion, the management of critically ill elderly patients should focus on adherence to SOPs as this was shown to be associated with a reduced ICU mortality rate. Implementation of evidence-based medicine and locally adapted SOPs is crucial in every ICU that cares for elderly patients. (Charité-Universitätsmedizin Berlin, Institute for Microbiology and Hygiene) for his continuous support of the SOP implementation. This study was supported by a grant (DFG SP 432/7-1) from the German Research Society and by inner university grants. 
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